search
Back to results

EXercise as TReatment for osteoArthritis (EXTRA)

Primary Purpose

Knee Osteoarthritis

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
NEMEX and education + strength training
NEMEX and education
Sponsored by
Slagelse Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Knee Osteoarthritis focused on measuring knee, osteoarthritis, exercise, quadriceps, strength, activities of daily living, treatment outcome

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patients with symptomatic and radiographically confirmed knee-OA who are found not eligible for knee replacement surgery by an orthopaedic surgeon in secondary health care.

Exclusion Criteria:

  • Kellgren & Lawrence score of <2 on radiography
  • Less than "mild" symptoms (mean score >75 in 0-100 KOOS-ADL)
  • Medication: Morphine for pain other than knee-joint pain
  • Previous ipsilateral knee arthroplasty
  • Rheumatoid arthritis
  • Inability to comply with the protocol
  • Inadequacy in written and spoken Danish

Sites / Locations

  • Department of planned Orthopaedic Surgery, Naestved Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

NEMEX and education + strength training

NEMEX and education

Arm Description

Participants will undergo 12 weeks of twice weekly exercise. Each exercise session will last for 70-90 min. and will consist of 1 hour of specific exercises to optimize sensorimotor control and achieve compensatory functional stability performed in a multiple-joint weight-bearing specific manner. The final part of the session will consist of focused knee extensor strength training performed in gym machines (knee extension & leg-press) in a combination of low-load fatiguing exercises (knee-extension) followed by high-load exercises (leg-press). Additionally, participants will receive 2 educational sessions, which include disease- and exercise specific counseling.

Participants will undergo 12 weeks of twice weekly exercise. Each exercise session will last for approximately 60 min. and will consist of 1 hour of specific exercises to optimize sensorimotor control and achieve compensatory functional stability performed in a multiple-joint weight-bearing specific manner. Additionally, participants will receive 2 educational sessions, which include disease- and exercise specific counseling.

Outcomes

Primary Outcome Measures

Knee injury and Osteoarthritis Outcome Score (KOOS) - subscale Activities of daily living (ADL)
KOOS is a validated and extensively used self-reported outcome measure for people with knee OA. KOOS consists of five subscales, of which the subscale KOOS-ADL will be the primary outcome for this study. KOOS-ADL consists of 17 questions, which are answered on a 4-point likert scale (0=no problems, 4=extreme problems). KOOS-ADL has demonstrated a test-retest reliability (ICC) of 0.84-0.94 as well as demonstrating responsiveness to change following physical therapy in knee osteoarthritis.

Secondary Outcome Measures

Muscle power (watt/kg. bodyweight)
Knee extensor muscle power (force times acceleration) will be measured using the Nottingham Power Rig (NPR). The NPR measures the power output in total watt and watt pr. bodyweight in kilograms from a seated push on a flat pedal which is transmitted by a lever and chain to spin a flywheel. The NPR is a safe and reliable method to measure explosive knee extensor muscle power and has been validated as a clinically important measure of muscle function in elderly individuals.
Functional performance (40 m walk & stair-climbs)
Assessment of functional performance involves time (in seconds) taken to complete a 40 m course at fast walking pace as well as time taken to negotiate 9 steps on a standard step-height stair-way. The tests are part of the recommended functional performance tests in knee osteoarthritis.
Pain medication
Assessment of pain medication intake specific for knee pain. Derived as part of self-reported outcome measure.
KOOS (remaining four subscales)
The four remaining subscales of the validated KOOS questionnaire (see primary outcome for further info on KOOS). The 4 remaining subscales cover: symptoms, pain, sport & recreation and quality of life.
AE (adverse events) & Serious Adverse Events (SAE)
Continous registration of health issues and injuries. Physiotherapists in charge of the training sessions will monitor potential AE and SAE. Also, during the follow-up visits at week 6 and week 12, the participants will be asked about potential AE's and SAE's using open-probe questions. Finally, the 12 month follow-up will include questions regarding AE's and SAE's during the preceding period from baseline to 12 months.

Full Information

First Posted
July 10, 2017
Last Updated
September 1, 2020
Sponsor
Slagelse Hospital
Collaborators
The Danish Rheumatism Association, Region Zealand, Naestved Hospital, University of Southern Denmark
search

1. Study Identification

Unique Protocol Identification Number
NCT03215602
Brief Title
EXercise as TReatment for osteoArthritis
Acronym
EXTRA
Official Title
EXercise as TReatment for osteoArthritis
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
July 18, 2017 (Actual)
Primary Completion Date
March 8, 2019 (Actual)
Study Completion Date
March 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Slagelse Hospital
Collaborators
The Danish Rheumatism Association, Region Zealand, Naestved Hospital, University of Southern Denmark

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Osteoarthritis (OA) of the knee is a chronic musculoskeletal disease, and a major cause of pain and disability worldwide. Exercise has previously demonstrated good effect in alleviating OA symptoms. However, optimal exercise modes in OA are currently unknown. This study seeks to evaluate the effects of supplementary focused, knee extensor strength training in addition to neuromuscular exercise (NEMEX) and education in people with OA of the knee as performed in Good Life with osteoArthritis in Denmark (GLA:D ᵀᴹ). Through a randomized design, study participants will either be allocated to 12 weeks (twice weekly) of NEMEX and education or 12 weeks (twice weekly) of NEMEX and education and focused, knee extensor strength training. The primary outcome measurement for this study is the Knee injury and Osteoarthritis Outcome Score, subscale Activities of Daily Living (KOOS-ADL), which is a self-reported questionnaire on daily life activities. Other outcomes include parameters of maximal muscle strength and muscle power, muscle imaging, physical function, pain and self-reported health status.
Detailed Description
Osteoarthritis (OA) is one of the most prevalent musculoskeletal diseases worldwide. In Denmark, it is estimated that approximately 900.000 people, or 1 out of 5 residents are suffering from OA in one or more joints. The annual socio-economic costs (treatment and loss of labour) as a direct consequence of OA in Denmark are estimated to 11.5 billion "Danish kroner" (DKK). Osteoarthritis of the knee is the most frequently reported and disabling OA subgroup and is mainly reported in middle-aged adults (≥40 years) with an increasing prevalence with increasing age. Knee osteoarthritis is associated with knee pain, loss of lower limb muscle strength, activity limitations and reduced quality of life. Moreover, pain sensitization, i.e. increased responsiveness of nociceptive neurons, is another mechanism involved in pain and disability in knee-OA and may contribute to the frequently reported disparities between pain symptoms and radiographic signs of structural damage. The current non-surgical treatment recommendations in Denmark as well as internationally include offering one or more of: Patient education, dietary advice, weight loss counselling and exercise. Exercise has proven to be a potent stimulus to improve function, and general quality of life in people with knee-OA. Moreover, exercise has been shown to reduce pain sensitization in knee-OA subjects with clinical signs of sensitization. However, there is still a paucity of information on the exact exercise mode for greatest beneficial effects in the knee-OA population. Reduced lower limb muscle strength has repeatedly been suggested as one of the main working mechanisms behind knee-OA symptoms and quadriceps muscle strength is even suggested as a potential mediating factor in future knee joint space narrowing and longitudinal worsening of knee-joint pain. A recent systematic review revealed upper leg muscle strength along with joint proprioception to be two of the most potent mediating factors in symptomatic knee-OA. In a randomized controlled trial (RCT) design, this study seeks to investigate potential added benefits of supplementing NEMEX and education with focused knee extensor strength training in patients with knee-OA. 90 patients deemed ineligible for knee replacement surgery will be recruited from the ambulatory setting at Naestved Hospital. By random allocation, patients will be recruited to either 12 weeks (twice weekly) of NEMEX and education + focused knee extensor strength training (intervention group) or 12 weeks (twice weekly) of NEMEX and education only (control group). The main outcome is the change in KOOS-ADL from baseline to 12-week follow-up. Other outcomes include the remaining KOOS subscales, self-reported pain, health status, physical activity and patient satisfaction, knee extensor muscle power and knee extensor maximal contractile strength, pain sensitization, MRI assessed thigh muscle quality and physical function.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis
Keywords
knee, osteoarthritis, exercise, quadriceps, strength, activities of daily living, treatment outcome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Parallel group, assessor- and patient blinded randomized controlled trial
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
One blinded outcome assessor (physiotherapists) will perform measurements of muscle strength, functional capacity and pain sensitization. The MRI scans will be performed by blinded radiologists. Patients in both groups will be blinded for parallel group assignments. Statistical analysis will be performed by a blinded statistician and a blinded interpretation of the results will be performed before breaking the randomization code.
Allocation
Randomized
Enrollment
90 (Actual)

8. Arms, Groups, and Interventions

Arm Title
NEMEX and education + strength training
Arm Type
Experimental
Arm Description
Participants will undergo 12 weeks of twice weekly exercise. Each exercise session will last for 70-90 min. and will consist of 1 hour of specific exercises to optimize sensorimotor control and achieve compensatory functional stability performed in a multiple-joint weight-bearing specific manner. The final part of the session will consist of focused knee extensor strength training performed in gym machines (knee extension & leg-press) in a combination of low-load fatiguing exercises (knee-extension) followed by high-load exercises (leg-press). Additionally, participants will receive 2 educational sessions, which include disease- and exercise specific counseling.
Arm Title
NEMEX and education
Arm Type
Active Comparator
Arm Description
Participants will undergo 12 weeks of twice weekly exercise. Each exercise session will last for approximately 60 min. and will consist of 1 hour of specific exercises to optimize sensorimotor control and achieve compensatory functional stability performed in a multiple-joint weight-bearing specific manner. Additionally, participants will receive 2 educational sessions, which include disease- and exercise specific counseling.
Intervention Type
Other
Intervention Name(s)
NEMEX and education + strength training
Other Intervention Name(s)
GLA:D + strength training
Intervention Description
Optimizing sensorimotor control and achieving functional stability. Increasing knee extensor muscle strength. Teaching everyday disease management.
Intervention Type
Other
Intervention Name(s)
NEMEX and education
Other Intervention Name(s)
GLA:D
Intervention Description
Optimizing sensorimotor control and achieving functional stability. Teaching everyday disease management.
Primary Outcome Measure Information:
Title
Knee injury and Osteoarthritis Outcome Score (KOOS) - subscale Activities of daily living (ADL)
Description
KOOS is a validated and extensively used self-reported outcome measure for people with knee OA. KOOS consists of five subscales, of which the subscale KOOS-ADL will be the primary outcome for this study. KOOS-ADL consists of 17 questions, which are answered on a 4-point likert scale (0=no problems, 4=extreme problems). KOOS-ADL has demonstrated a test-retest reliability (ICC) of 0.84-0.94 as well as demonstrating responsiveness to change following physical therapy in knee osteoarthritis.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoints: 6 weeks & 12 months.
Secondary Outcome Measure Information:
Title
Muscle power (watt/kg. bodyweight)
Description
Knee extensor muscle power (force times acceleration) will be measured using the Nottingham Power Rig (NPR). The NPR measures the power output in total watt and watt pr. bodyweight in kilograms from a seated push on a flat pedal which is transmitted by a lever and chain to spin a flywheel. The NPR is a safe and reliable method to measure explosive knee extensor muscle power and has been validated as a clinically important measure of muscle function in elderly individuals.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoint: Baseline to 6 weeks.
Title
Functional performance (40 m walk & stair-climbs)
Description
Assessment of functional performance involves time (in seconds) taken to complete a 40 m course at fast walking pace as well as time taken to negotiate 9 steps on a standard step-height stair-way. The tests are part of the recommended functional performance tests in knee osteoarthritis.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoint: 6 weeks.
Title
Pain medication
Description
Assessment of pain medication intake specific for knee pain. Derived as part of self-reported outcome measure.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoints: 6 weeks & 12 months.
Title
KOOS (remaining four subscales)
Description
The four remaining subscales of the validated KOOS questionnaire (see primary outcome for further info on KOOS). The 4 remaining subscales cover: symptoms, pain, sport & recreation and quality of life.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoints: 6 weeks & 12 months.
Title
AE (adverse events) & Serious Adverse Events (SAE)
Description
Continous registration of health issues and injuries. Physiotherapists in charge of the training sessions will monitor potential AE and SAE. Also, during the follow-up visits at week 6 and week 12, the participants will be asked about potential AE's and SAE's using open-probe questions. Finally, the 12 month follow-up will include questions regarding AE's and SAE's during the preceding period from baseline to 12 months.
Time Frame
Primary endpoint: From baseline to 12 weeks.. Secondary endpoint: 12 months.
Other Pre-specified Outcome Measures:
Title
Pain sensitization
Description
Pan sensitization will be assessed through pain pressure cuff algometry (PPCA). The assessment involves placing a pneumatic pressure cuff with automatic inflation around the participant's lower leg. Through four different tests, the participant is asked to rate pain intensity (VAS). The pain scores along with cuff pressure (kPa) is registered. The PPCA is an increasingly used measure of deep-tissue pain sensitization, which allows for multimodal measurements of pain mechanisms in the knee-OA population.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoint: 6 weeks.
Title
MRI derived muscle quality assessment
Description
In order to assess morphologic changes and changes in muscle quality of the knee extensors, patients will undergo two MRI scans (baseline & follow-up). MRI is considered the gold standard in assessing morphometric muscle changes in humans.
Time Frame
Primary endpoint: Change from baseline to 12 weeks.
Title
Knee extensor isokinetic dynamometry
Description
Isokinetic dynamometry will be conducted in order to assess the contractile properties of the knee extensors. The dynamometry assessments will allow for specific strength evaluations and is a validated measure of maximal contractile muscle strength.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoint: 6 weeks.
Title
Functional performance (chair rise)
Description
The 30 sec chair-rise (total reps) is part of the recommended functional performance tests in knee OA.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoint: 6 weeks..
Title
Visual Analog Scale (VAS)
Description
VAS will be derived for the questions: last 24 hours, last week and after 30 min. of walking.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoint: 6 weeks.
Title
Widespread Pain Index (WPI)
Description
WPI will be assessed by questions on regional body pain as validated by the American College of Rheumatology.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoint: 6 weeks & 12 months.
Title
Numeric Rating Scale (NRS)
Description
NRS will be derived before, during and after each exercise session as well as before and after each testing procedure. The NRS assessments will allow for an evaluation of the effects of exercise and functional activities on self-reported pain ratings.
Time Frame
Continuous assessments from baseline to 12 weeks.
Title
Physical activity level
Description
Patient reported physical activity levels.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary outcomes: 6 weeks & 12 months.
Title
Compliance with exercise
Description
The number of exercise sessions that the patient participates in out of the total 24 supervised sessions.
Time Frame
Primary endpoint: 12 weeks..
Title
Surgery and other treatments during follow-up
Description
Self-reported assessment at baseline, 6 and 12 weeks and at 12 months.
Time Frame
Primary endpoint: 12 weeks. Secondary endpoints: 6 weeks & 12 months.
Title
EuroQOL 5 domain
Description
A self-reported outcome measure of health-related quality of life, covering 5 dimensions (movement, personal care, everyday activities, pain/discomfort and anxiety/depression). Is translated and validated for use in a Danish population.
Time Frame
Primary endpoint: Change from baseline to 12 weeks. Secondary endpoints: 6 weeks & 12 months.
Title
Patient Acceptable Symptom State (PASS)
Description
PASS registers how patients perceive their current symptom state. Answered by "yes" or "no" to the question; "When you think of your knee function, will you consider your current condition as satisfying?".
Time Frame
Primary endpoint: 12 weeks. Secondary endpoint: 6 weeks & 12 months.
Title
Global Perceived Effect (GPE)
Description
GPE registers how patients perceive the effects of the interventions on a 7-point likert scale.
Time Frame
Primary endpoint: 12 weeks. Secondary endpoints: 6 weeks & 12 months.
Title
Treatment Failure (TF)
Description
Only answered by patients answering "no" to PASS. TF registers if the patients perceive the intervention as failed. Answered by "yes" or "no" to the question; "Would you consider your current state as being so unsatisfactory that you consider the treatment to have failed?".
Time Frame
Primary endpoint: 12 weeks. Secondary endpoint: 12 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with symptomatic and radiographically confirmed knee-OA who are found not eligible for knee replacement surgery by an orthopaedic surgeon in secondary health care. Exclusion Criteria: Kellgren & Lawrence score of <2 on radiography Less than "mild" symptoms (mean score >75 in 0-100 KOOS-ADL) Medication: Morphine for pain other than knee-joint pain Previous ipsilateral knee arthroplasty Rheumatoid arthritis Inability to comply with the protocol Inadequacy in written and spoken Danish
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pætur M Holm, PT, MSc
Organizational Affiliation
University of Southern Denmark and Department of Physiotherapy and Occupational Therapy, Naestved-Slagelse-Ringsted Hospitals.
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Søren T Skou, PT, PhD
Organizational Affiliation
University of Southern Denmark and Naestved-Slagelse-Ringsted Hospitals.
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Henrik M Schøder, MD
Organizational Affiliation
Naestved Hospital
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Mathias Wernbom, PT, PhD
Organizational Affiliation
Göteborg University
Official's Role
Study Chair
Facility Information:
Facility Name
Department of planned Orthopaedic Surgery, Naestved Hospital
City
Naestved
State/Province
Region Zealand
ZIP/Postal Code
4700
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
33021580
Citation
Holm PM, Kemnitz J, Bandholm T, Wernbom M, Schroder HM, Skou ST. Muscle Function Tests as Supportive Outcome Measures for Performance-Based and Self-Reported Physical Function in Patients With Knee Osteoarthritis: Exploratory Analysis of Baseline Data From a Randomized Trial. J Strength Cond Res. 2022 Sep 1;36(9):2635-2642. doi: 10.1519/JSC.0000000000003840. Epub 2020 Oct 5.
Results Reference
derived
PubMed Identifier
32304510
Citation
Holm PM, Nyberg M, Wernbom M, Schroder HM, Skou ST. Intrarater Reliability and Agreement of Recommended Performance-Based Tests and Common Muscle Function Tests in Knee Osteoarthritis. J Geriatr Phys Ther. 2021 Jul-Sep 01;44(3):144-152. doi: 10.1519/JPT.0000000000000266.
Results Reference
derived
PubMed Identifier
32179197
Citation
Holm PM, Schroder HM, Wernbom M, Skou ST. Low-dose strength training in addition to neuromuscular exercise and education in patients with knee osteoarthritis in secondary care - a randomized controlled trial. Osteoarthritis Cartilage. 2020 Jun;28(6):744-754. doi: 10.1016/j.joca.2020.02.839. Epub 2020 Mar 13.
Results Reference
derived

Learn more about this trial

EXercise as TReatment for osteoArthritis

We'll reach out to this number within 24 hrs